Breast cancer
Results
Phase 3
This trial was trying to find out if radiotherapy to the brain can prevent breast cancer spreading to the brain (brain secondaries or metastases). It was for women who were due to have treatment with trastuzumab (Herceptin) for breast cancer that is locally advanced or had spread elsewhere in the body. This trial was supported by Cancer Research UK.
Recruitment start: 2 March 2007
Recruitment end: 30 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Peter Canney
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/07/002.
Last reviewed: 26 November 2015
CRUK internal database number: 704
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
